Md. Lebowitz et al., ASTHMATIC RISK-FACTORS AND BRONCHIAL REACTIVITY IN NON-DIAGNOSED ASTHMATIC ADULTS, European journal of epidemiology, 11(5), 1995, pp. 541-548
Specific respiratory signs and symptoms are thought to occur prior to
diagnoses of asthma as part of the natural history. These signs and sy
mptoms include: high IgE, a history of wheezing symptoms, and/or exces
sive declines in lung function. The first two are thought to distingui
sh asthma from other airway obstructive diseases (AOD). To predict sub
sequent AOD, twelve years of follow-up (1972-84) data from the Tucson
longitudinal epidemiological study of AOD in a community population we
re evaluated on 687 subjects aged 19-70 years on entry. To determine t
he likelihood that non-asthmatics that have these specific risk factor
s would have marked or intermediate bronchial reactivity to methacholi
ne, an experimental study was performed. This was done in 1984-85 in a
robust, efficient post-hoc stratified sample of male subjects ages 30
-55 from the population followed from 1972. They were subsequently fol
lowed through 1991. Persistent symptoms best predicted final pulmonary
function and new diagnosed AOD in subjects in the population. Previou
sly diagnosed AOD also predicted lower pulmonary function. The experim
ental results indicate that predisposition to reactivity appears likel
y without the presence of diagnosed asthma. Further, the experimental
subjects with high risk had increased symptomatology and decreased lun
g function when tested at follow-up; nor all of the reactivity was exp
lained by these factors. An attempt to predict reactivity by physician
evaluation and special questionnaire was not fruitful. In addition, w
heeze per se often disappeared without later evidence of asthma (or AO
D) diagnosis, questioning some international tendencies to label all w
heeze as asthma. Thus, high IgE significantly predicted bronchial resp
onsiveness, but high IgE and symptoms are neither necessary nor suffic
ient. Also, both preclinical and clinical asthma predict eventual low
lung function.